Media

Press releases and topics in the spotlight

Welcome to our media section. Check out the latest interviews, news, and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information.

Media gallery

Latest pressreleases

See all Subscribe

In the spotlight

Christer Ahlberg interviewed by Redeye about the Q2 report and HEEALING1

2026-08-19

Cinclus Pharma CEO Christer Ahlberg discusses the Q2 2026 Interim Report and provides an update on the Phase III HEEALING1 trial in an interview with Redeye.

Watch the full presentation from Jefferies Global Healthcare Conference

2026-06-16

CEO Christer Ahlberg presents the company and the drug candidate, linaprazan glurate.

Cinclus Pharma is proud to be the Gold Sponsor of the OESO-SEMPIRE World Conference in Esophagology

2026-05-25

This international congress brings together leading experts, researchers and healthcare professionals from around the world to share knowledge, discuss the latest advances in esophagology, and shape the future of esophageal care and treatment.

Cinclus Pharma participates in Digestive Disease Week (DDW) in Chicago May 2-5 2026

2026-04-30

DDW brings together experts from across the globe for a comprehensive program of scientific sessions and networking opportunities.

See all

Cinclus Pharma in media

Interview with Christer Ahlberg in BioStock

2026-06-09

Read article about Cinclus Pharma with interview with CEO Christer Ahlberg from BioStock (in Swedish).

Kjell Andersson in the Lonza Podcast: A View On: Developing Acid Reflux Therapy

2025-03-06

Kjell Anderson, Chief Scientific Officer and Founder of Cinclus Pharma, discusses a novel treatment for acid reflux in this episode ‘A View On: Developing Acid Reflux Therapy’ of the Lonza podcast.

Placera.se lists Swedish stocks offering the biggest upside

2025-01-02

Cinclus Pharma is on the list of analysts' favorite stocks when Placera.se lists Swedish stocks offering the biggest upside.

Bengt Julander on Cinclus Pharma in DITV

2024-12-11

Bengt Julander, Chairman of one of Cinclus Pharma's largest shareholders, Linc, participated in DITV, saying Cinclus Pharma has the world's best stomach ulcer treatment.